Filter Results:
(812)
Show Results For
- All HBS Web
(1,476)
- People (4)
- News (400)
- Research (812)
- Events (2)
- Multimedia (16)
- Faculty Publications (564)
Show Results For
- All HBS Web
(1,476)
- People (4)
- News (400)
- Research (812)
- Events (2)
- Multimedia (16)
- Faculty Publications (564)
Sort by
- 22 Apr 2007
- Other Presentation
Redefining Competition in Health Care
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and "How Physicians Can Change the Future of Health Care," Journal of the American... View Details
Porter, Michael E. "Redefining Competition in Health Care." 4th World Health Care Congress, Washington, DC, April 22, 2007.
- 28 Sep 2007
- Other Presentation
Value-Based Competition in Health Care
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and "How Physicians Can Change the Future of Health Care," Journal of the... View Details
Porter, Michael E. "Value-Based Competition in Health Care." Harvard Business School Alumni Reunion, Boston, MA, September 28, 2007.
- April 2010 (Revised April 2010)
- Teaching Note
Managing Orthopaedics at Rittenhouse Medical Center (TN)
By: Robert S. Huckman and Richard M.J. Bohmer
Teaching Note for [607152]. View Details
- August 2010 (Revised May 2012)
- Teaching Note
The UCLA Medical Center: Kidney Transplantation (TN)
By: Michael E. Porter and Jennifer F Baron
Teaching Note for 711410. View Details
- Article
Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries
By: Ariel Dora Stern, William J. Gordon, Adam B. Landman and Daniel B. Kramer
Objectives:
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
To more clearly define the landscape of digital medical devices subject to U.S. Food and Drug Administration (FDA) oversight, this analysis leverages publicly available regulatory documents to characterise the prevalence and trends of software and... View Details
Keywords: Digital; Medicine; FDA; Health Care and Treatment; Applications and Software; Safety; Cybersecurity; Medical Devices and Supplies Industry
Stern, Ariel Dora, William J. Gordon, Adam B. Landman, and Daniel B. Kramer. "Cybersecurity Features of Digital Medical Devices: An Analysis of FDA Product Summaries." BMJ Open 9, no. 6 (June 2019).
- Article
Decisions about Medication Use and Cancer Screening across Age Groups in the United States
By: Kathleen M. Fairfield, Bethany S. Gerstein, Carrie A. Levin, Vickie Stringfellow, Heidi Wierman and Mary McNaughton-Collins
Objective
To describe decision process and quality for common cancer screening and medication decisions by age group.
Methods
We included 2941 respondents to a national Internet survey who made at least one decision about colorectal, breast,... View Details
To describe decision process and quality for common cancer screening and medication decisions by age group.
Methods
We included 2941 respondents to a national Internet survey who made at least one decision about colorectal, breast,... View Details
Fairfield, Kathleen M., Bethany S. Gerstein, Carrie A. Levin, Vickie Stringfellow, Heidi Wierman, and Mary McNaughton-Collins. "Decisions about Medication Use and Cancer Screening across Age Groups in the United States." Patient Education and Counseling 98, no. 3 (March 2015): 338–343.
- March 2015 (Revised November 2017)
- Case
Bonitas
By: Regina E. Herzlinger and Natalie Kindred
Bonitas, a South African medical scheme (i.e., health insurer), must navigate highly restrictive regulations that make it difficult for Bonitas to innovate, grow, and compete with market leader Discovery as well as providers of alternative insurance products. Bonitas... View Details
Keywords: Health Insurance; Health Care; South Africa; Medical Scheme; Public Policy; Bonitas; Bonitas Medical Fund; National Health Insurance; Health; Health Care and Treatment; Insurance; Policy; Health Industry; Insurance Industry; South Africa; Johannesburg; Africa
Herzlinger, Regina E., and Natalie Kindred. "Bonitas." Harvard Business School Case 315-020, March 2015. (Revised November 2017.)
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
lower-cost venues of care more capable that health care becomes affordable, not by expecting large hospitals to charge less. Q: Could you give an example of a technological innovation that you think will... View Details
- March 2015 (Revised January 2024)
- Case
CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies
By: Regina E. Herzlinger and Andrew Otazo
Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details
Keywords: CV Ingenuity; CVI; Drug Eluting Balloon; DEB; Drug Eluting Stent; Angioplasty Balloon; FoxHollow; Medical Device; Medical Device Startup; Premarket Approval; PMA; Lutonix; Stellarex; LEVANT; ILLUMENATE; Clinical Trials; Peripheral Arterial Disease; PAD; Healthcare Startups; Covidien; Health Care and Treatment; Health Testing and Trials; Business Startups; Commercialization; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States; Europe
Herzlinger, Regina E., and Andrew Otazo. "CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies." Harvard Business School Case 315-045, March 2015. (Revised January 2024.)
- February 1993 (Revised August 1995)
- Case
Medicare Payment for Drugs and Medical Devices
Keywords: Health Care and Treatment; Business and Government Relations; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry
Herzlinger, Regina E. "Medicare Payment for Drugs and Medical Devices." Harvard Business School Case 193-099, February 1993. (Revised August 1995.)
- 6 Jan 2009
- Other Presentation
Introduction to Value-Based Health Care Delivery
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and ―How Physicians Can Change the Future of Health Care, Journal of the American... View Details
Porter, Michael E. "Introduction to Value-Based Health Care Delivery." Value-Based Healthcare Delivery, Harvard Business School, Boston, MA, January 6, 2009.
- January 2000 (Revised February 2007)
- Case
Asia Renal Care
Presents a business plan for a start-up company focused on building a network of high-quality dialysis centers in the Asia-Pacific region. Includes a detailed financial forecast. An executable spreadsheet is available by contacting HBSP Customer Service at... View Details
Keywords: Business Plan; Forecasting and Prediction; Business Startups; Financial Strategy; Medical Devices and Supplies Industry; Asia
Roberts, Michael J. "Asia Renal Care." Harvard Business School Case 800-243, January 2000. (Revised February 2007.)
- September 2011
- Article
How to Solve the Cost Crisis in Health Care
By: Robert S. Kaplan and Michael E. Porter
Existing health care costing systems have serious flaws that make it impossible to measure costs accurately at the individual patient and medical condition level. This gap has severely limited meaningful cost reduction throughout the system. The paper describes a new... View Details
Keywords: Cost; Health Care and Treatment; Measurement and Metrics; Service Delivery; Outcome or Result; Quality; Health Industry
Kaplan, Robert S., and Michael E. Porter. "How to Solve the Cost Crisis in Health Care." Harvard Business Review 89, no. 9 (September 2011): 47–64.
- 2023
- Article
Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma
By: Nazlı Sönmez, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell and Kamalini Ramdas
In Shared Medical Appointments (SMAs), patients with similar conditions meet the physician together and each receives one-on-one attention. SMAs can improve outcomes and physician productivity. Yet privacy concerns have stymied adoption. In physician-deprived nations,... View Details
Sönmez, Nazlı, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell, and Kamalini Ramdas. "Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma." e0001648. PLoS Global Public Health 3, no. 7 (2023).
- 07 Mar 2018
- Research & Ideas
Electronic Health Records Were Supposed to Cut Medical Costs. They Haven't.
annoyed, and it distracts them from dealing with the patient.” The study, published in the February 20 issue of the Journal of the American Medical Association, looked at five types of visits: primary care... View Details
- 10 Dec 2008
- Other Presentation
New Research: Value-Based Health Care Delivery
By: Michael E. Porter and Rebecca Weintraub
This presentation draws on Michael E. Porter and Elizabeth Olmsted Teisberg: Redefining Health Care: Creating Value-Based Competition on Results, Harvard Business School Press, May 2006, and "How Physicians Can Change the Future of Health Care," Journal of the... View Details
Porter, Michael E., and Rebecca Weintraub. "New Research: Value-Based Health Care Delivery." Microeconomics of Competitiveness Faculty Workshop, Institute for Strategy and Competitiveness, Boston, MA, December 10, 2008.
- March 1997 (Revised March 1998)
- Case
Help the World See: Self-Sustaining Eye Care in Belize
In 1992, Help the World See (HTWS), a U.S. nonprofit organization dedicated to improving eye care in developing countries, established permanent, self-sustaining eye care clinics in Belize in conjunction with the Belize Council for the Visually Impaired (BCVI). The... View Details
Keywords: Conflict of Interests; Nonprofit Organizations; Health Care and Treatment; Health Industry; Belize
Dees, J. Gregory, Jaan Elias, and Jeffrey Orenstein. "Help the World See: Self-Sustaining Eye Care in Belize." Harvard Business School Case 897-142, March 1997. (Revised March 1998.)
- March 2003
- Article
Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State
By: David M. Cutler and Robert S. Huckman
A puzzling feature of many medical innovations is that they simultaneously appear to reduce unit costs and increase total costs. We consider this phenomenon by examining the diffusion of percutaneous transluminal coronary angioplasty (PTCA)—a treatment for coronary... View Details
Keywords: Innovation and Invention; Cost; Health Care and Treatment; Health Disorders; Performance Improvement; Product; New York (state, US)
Cutler, David M., and Robert S. Huckman. "Technological Development and Medical Productivity: The Diffusion of Angioplasty in New York State." Journal of Health Economics 22, no. 2 (March 2003): 187–217.
- 04 Jun 2007
- Research & Ideas
Is Health Care Making You Better—or Dead?
Regina Herzlinger is not afraid to call them as she sees them. And what she sees looking at the American health care industry is a bunch of killers. Not only are hospitals, insurers, employers, Congress, and academics killing health care,... View Details
- Research Summary
Overview
Phil's work aims to identify the drivers of performance for healthcare organizations and providers, and the mechanisms by which this performance can change over time. In complex healthcare settings, the optimal choice of treatment can be highly ambiguous. As a... View Details